New Vaccine Post-Introduction Evaluation - libdoc.who.int - World ...

2.10 Advocacy, communication and acceptance
Advocacy and communication efforts are linked to community acceptance of the new
vaccine. Messages and methods for their dissemination need to be tailored to the target
audience.
•
•
•
•
Ask about promotional launch efforts for the new vaccine, particularly at the
central level.
At central level, ask what steps were taken to make sure that the messages and
information are both relevant to, and understood and accepted by, their target
audiences. Include evidence of pre-testing of messages.
Look for evidence of health information and education efforts, such as posters,
flyers and brochures, and assess their accuracy and relevance to the target
audience.
Ask about the use of community-based information dissemination channels
(e.g. community and religious leaders, outreach workers, traditional birth
attendants, and other community peers).
To evaluate community acceptance, interview 2–5 parents or guardians of children who
have just received the new vaccine, at each clinic visited, to seek anecdotal evidence
of vaccine acceptability (Appendix 2.3). Groups of caretakers can also be interviewed.
If no children have been vaccinated when the evaluator is onsite, general questions
can be asked of parents to elicit knowledge and acceptance of the vaccine. Health-care
workers should also be asked to describe their experience of administering an additional
vaccine, as their acceptance will influence the acceptability by the caregivers.
•
•
•
Ask what injection the infant received.
Ask if parents or guardians heard about the new vaccine and the disease that it
prevents.
For vaccines requiring an additional injection at an immunization visit, such as
yellow fever or pneumococcal conjugate vaccine (PCV), ask if the additional
injection influenced the decision whether or not to receive the vaccination.
Evaluate the health-care worker’s reaction to delivering an additional vaccine.
WHO/IVB/10.03
17